We are happy you shared the first part of our newsletter mini-series, in which we elaborate the power of LBAs for drug molecule characterization.
Episode 2 on ADA assays is coming to you next week!
Subscribe here: https://lnkd.in/djsYPcS
Are you restricted in accessing the site of action of your medicine?
Chimera Biotec can quantify low concentrations from minimal sample volumes - even when they are drawn far from the site of action.
Lear more: https://www.chimera-biotec.com/about-us/blog-news/
This months´ newletter features Autoimmune Disease
Read our two interesting case studies about cytokines from serum and synovial fluid from Arthritis patients.
https://www.chimera-biotec.com/about-us/blog-news/
Read Chimera´s success story on how we developed ultra sensitive Immunoassays, capable of discriminating vaccine-specific mucosal antibodies and total immune response.
https://www.chimera-biotec.com/about-us/blog-news/
